Emerging Drugs & Toxicology Bundle (2025-2026 Recordings)
Availability
On-Demand
6 Courses
Access expires on Jun 30, 2027
Cost
Member: Not Eligible
Non-Member: $159.00
This package is part of the full 2025–2026 Didactic Series—ACAAM members can access all sessions within the complete bundle; join ACAAM to unlock the full collection and more.

This bundle provides a focused review of emerging and high-risk substances in addiction medicine, emphasizing the recognition and management of evolving drug trends and complex toxicologic presentations.

What This Covers
• Novel psychoactive substances and evolving drug supply trends
• Synthetic opioids and emerging high-potency compounds
• Toxicology and interpretation of complex or unexpected substance exposures
• Nicotine, vaping, and electronic nicotine delivery systems
• Hallucinogens and emerging therapeutic and recreational use patterns
• Performance-enhancing drugs and nontraditional substance use

How This Resource Is Used
This bundle is designed for applied learning and rapid clinical recognition. It can be used to strengthen understanding of emerging substances, interpret complex presentations, and support clinical decision-making in dynamic care environments.

This collection supports clinicians in responding to the evolving drug landscape, building confidence in managing unfamiliar substances and multi-substance exposures in real-world practice.

This bundle includes 6 applied didactic sessions focused on emerging substances and evolving trends in addiction medicine:

Nitazenes and Medetomidine Update
Emerging synthetic opioids and sedatives, overdose risk, and clinical implications

Toxicology: Drug Testing in Addiction Medicine
Testing modalities, result interpretation, and limitations in clinical practice

Novel Psychoactive Substances
Emerging synthetic compounds, patterns of use, and clinical presentation

Vaping and Tobacco Use: Epidemiology, Regulation, and Safety
Nicotine products, health risks, and evolving regulatory considerations

Hallucinogen Use Disorders and Psychedelics in Treatment
Clinical effects, use patterns, and emerging therapeutic applications

Anabolic-Androgenic Steroids
Patterns of use, health effects, and clinical management considerations

These sessions provide clinically focused content to support recognition and management of emerging substances and complex toxicologic presentations.

Access Period
Access to this bundle is available through June 30, 2027, in alignment with ACAAM’s annual academic cycle.

Recording Release Cycle
ACAAM releases updated recorded sessions each July based on the prior academic year’s didactic series. These recordings are available for a limited time and are retired on June 30 of the following year as new content is released.

Powered By